drugset

drugset / Trial / NCT05354752

Multiple-dose Escalation Clinical Study of VC005 Tablets in Healthy Subjects

NCT05354752 ↗

Phase 1 Completed 60 enrolled Jiangsu vcare pharmaceutical technology co., LTD

RandomizedSequentialDouble-blindTreatment

Summary

This clinical trial is a randomized, double-blind, single-center, placebo-controlled and multiple-dose escalation Pharmacokinetics study

Timeline

Start: 2022-06-18
Primary completion: 2022-11-02
Completion: 2022-11-15

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	VC005	Unknown	—	—

Indications